2019
DOI: 10.1007/s13318-019-00576-6
|View full text |Cite
|
Sign up to set email alerts
|

Excretion, Metabolism and Cytochrome P450 Inhibition of Methyl 3,4-Dihydroxybenzoate (MDHB): A Potential Candidate to Treat Neurodegenerative Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 33 publications
0
0
0
Order By: Relevance
“…Twenty pathways, such as signaling pathways, are involved. Modern pharmacological studies have shown that hydroxybenzoic acid, hydroxybenzaldehyde, and 3, 4‐dihydroxybenzoic acid methyl ester all have varying degrees of antibacterial, anti‐inflammatory, anti‐corrosion, anti‐tumor, and deodorizing activity 18,26–30 . To further determine the Q‐markers of PFH, HCA, PCA, and OPLS‐DA, pattern recognition techniques were used to analyze the major components affecting the quality of PFH medicinal materials.…”
Section: Resultsmentioning
confidence: 99%
“…Twenty pathways, such as signaling pathways, are involved. Modern pharmacological studies have shown that hydroxybenzoic acid, hydroxybenzaldehyde, and 3, 4‐dihydroxybenzoic acid methyl ester all have varying degrees of antibacterial, anti‐inflammatory, anti‐corrosion, anti‐tumor, and deodorizing activity 18,26–30 . To further determine the Q‐markers of PFH, HCA, PCA, and OPLS‐DA, pattern recognition techniques were used to analyze the major components affecting the quality of PFH medicinal materials.…”
Section: Resultsmentioning
confidence: 99%